False negatives in the newborn screening for cystic fibrosis in Western Andalusia: Results from a 10‐year experience
Pediatric Pulmonology · 2023
DOI: 10.1002/ppul.26183 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Pulmonology, 2023. Verfasst von Rocío Escudero-Ávila und 5 weiteren Autor:innen. Beteiligte Einrichtung: Unidad de Neumología Pediátrica, Hospital Infantil Virgen del Rocío, Sevilla, España. Hauptthemen laut MEDLINE: Cystic Fibrosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 13 Literaturangaben.
Abstract (Originalsprache)
Cystic fibrosis (CF) is the most common autosomal recessive disorder in the Caucasian population, with an incidence of 1:5000 live births. In 2011, the screening of CF was implemented in the Andalusian Public Health newborn screening program by using immunoreactive trypsinogen and chloride sweat test (IRT/IRT/sweat test) determinations. Since then, 79 children have been diagnosed with CF in our health area (Western Andalusia). The aim of this study was to evaluate the efficiency of this screening method and to examinate the characteristics of those CF infants who had a negative screening but who were later diagnosed. In the 2011–2021 period 462,049 newborns were screened for CF using a two‐step IRT determination and chloride sweat test. Sixty‐three infants were diagnosed with CF in our health area thanks to the screening, and 15 CF children had a negative screening result and were finally diagnosed by molecular sequencing of the CFTR gene. The most frequent symptoms that led to the diagnosis of those false negative (FN) patients were hyponatremic dehydration (mean age 9.75 ± 1.5 months) and recurrent wheezing (mean age 24 ± 14.5 months). The molecular analysis of the CFTR gene on those FN showed a diversity of genotypes, identifying more than 10 different mutations. Conclusion The rate of FN patients obtained in this study is inadmissibly high, and the protocol used in this region has not been updated despite the advances in genetic testing in the past 10 years. An improvement on CF newborn screening should be implemented, adding molecular analysis of the CFTR gene.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Unidad de Neumología Pediátrica, Hospital Infantil Virgen del Rocío, Sevilla, España.
- Unidad de Metabolopatías, Hospital Universitario Virgen del Rocío, Sevilla, España.
- Unidad de Fibrosis Quística, Hospital Universitario Virgen del Rocío, Sevilla, España.
- CIBER de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, España, Sevilla, España.
- Dpto. de Pediatría, Universidad de Sevilla, Sevilla, España.
ORCID-Profile: Rocío Escudero-Ávila
Zitieren
APA
Escudero-Ávila, R., Delgado-Pecellín, C., Moreno-Valera, M. J., Carrasco-Hernández, L., Quintana-Gallego, M. E., & Delgado-Pecellín, I. (2023). False negatives in the newborn screening for cystic fibrosis in Western Andalusia: Results from a 10‐year experience. Pediatric Pulmonology. https://doi.org/10.1002/ppul.26183
Vancouver
Escudero-Ávila R, Delgado-Pecellín C, Moreno-Valera MJ, Carrasco-Hernández L, Quintana-Gallego ME, Delgado-Pecellín I. False negatives in the newborn screening for cystic fibrosis in Western Andalusia: Results from a 10‐year experience. Pediatric Pulmonology. 2023. doi:10.1002/ppul.26183
BibTeX
@article{Escuderovila2023,
author = {Escudero-Ávila, Rocío and Delgado-Pecellín, Carmen and Moreno-Valera, M José and Carrasco-Hernández, Laura and Quintana-Gallego, M Esther and Delgado-Pecellín, Isabel},
title = {False negatives in the newborn screening for cystic fibrosis in Western Andalusia: Results from a 10‐year experience},
journal = {Pediatric Pulmonology},
year = {2023},
doi = {10.1002/ppul.26183}
}
EUVIMED